Ryll Thomas

SVP, Technical Operations at ImmunoGen, Inc.

Sold, on record
$277k
Dollars the filings state
Form 4 sales
3
Latest Feb 24, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ImmunoGen, Inc.Plan not stated
    Feb 21 2018

    Sold 11,876 shares at $10.88 ($129k)

    Ryll Thomas, VP, Technical Operations

    Sold 11% of holdings ($1.2M position)96,224 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ImmunoGen, Inc.Plan not stated
    Feb 22 +1 day

    Sold 11,495 shares at $5.60 ($64k)

    Ryll Thomas, VP, Technical Operations

    Sold 11.6% of holdings ($553k position)87,184 shares leftFiling

  3. 3 Form 4 sale ImmunoGen, Inc.Plan not stated
    Feb 24 +732 days

    Sold 16,790 shares at $4.99 ($84k)

    Ryll Thomas, SVP, Technical Operations

    Sold 18.2% of holdings ($461k position)75,624 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Ryll Thomas
Source
Feb 24, 2020ImmunoGen, Inc.SVP, Technical OperationsForm 4 sale16,790$84k18.2%Plan not statedSEC
Feb 22, 2018ImmunoGen, Inc.VP, Technical OperationsForm 4 sale11,495$64k11.6%Plan not statedSEC
Feb 21, 2018ImmunoGen, Inc.VP, Technical OperationsForm 4 sale11,876$129k11.0%Plan not statedSEC